Haloprogin and nystatin therapy for cutaneous candidiasis. Comparison of the efficacy of haloprogin and nystatin therapy.
D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans / Q000302:isolation & purification; D002179:Candidiasis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006878:Hydroxides; D008297:Male; D009761:Nystatin / Q000008:administration & dosage / Q000627:therapeutic use*; D009824:Ointments; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011188:Potassium
D000935:Antifungal Agents; D006878:Hydroxides; D009824:Ointments; D010647:Phenyl Ethers; D009761:Nystatin; D011188:Potassium